Van Damme P - Search Results

1

Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.

Van Herck K, Leroux-Roels G, Van Damme P, Srinivasa K, Hoet B. Van Herck K, et al. Among authors: van damme p. Travel Med Infect Dis. 2007 May;5(3):171-5. doi: 10.1016/j.tmaid.2006.07.003. Epub 2006 Sep 20. Travel Med Infect Dis. 2007. PMID: 17448944 Clinical Trial.

2

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results.

Van Herck K, Van Damme P, Thoelen S, Meheus A. Van Herck K, et al. Among authors: van damme p. Vaccine. 1998 Dec;16(20):1933-5. doi: 10.1016/s0264-410x(98)00126-1. Vaccine. 1998. PMID: 9796046

3

Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.

Van Herck K, Van Damme P, Collard F, Thoelen S. Van Herck K, et al. Among authors: van damme p. Scand J Gastroenterol. 1999 Dec;34(12):1236-40. doi: 10.1080/003655299750024760. Scand J Gastroenterol. 1999. PMID: 10636072 Clinical Trial.

4

Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.

Van Herck K, Van Damme P. Van Herck K, et al. Among authors: van damme p. J Med Virol. 2001 Jan;63(1):1-7. J Med Virol. 2001. PMID: 11130881 Clinical Trial.

5

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.

Van Damme P, Leroux-Roels G, Law B, Diaz-Mitoma F, Desombere I, Collard F, Tornieporth N, Van Herck K. Van Damme P, et al. Among authors: van herck k. J Med Virol. 2001 Sep;65(1):6-13. J Med Virol. 2001. PMID: 11505437 Clinical Trial.

6

Hepatitis A booster vaccination: is there a need?

Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G, Leroux-Roels G, Von Sonnenburg F; International Consensus Group on Hepatitis A Virus Immunity. Van Damme P, et al. Among authors: van herck k. Lancet. 2003 Sep 27;362(9389):1065-71. doi: 10.1016/S0140-6736(03)14418-2. Lancet. 2003. PMID: 14522539 Review.

7

Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance.

Van Herck K, Leuridan E, Van Damme P. Van Herck K, et al. Among authors: van damme p. Sex Transm Infect. 2007 Oct;83(6):426-32. doi: 10.1136/sti.2006.022111. Sex Transm Infect. 2007. PMID: 17911142 Free PMC article. Review.

8

Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine.

Van Damme P, Leroux-Roels G, Crasta P, Messier M, Jacquet JM, Van Herck K. Van Damme P, et al. Among authors: van herck k. J Med Virol. 2012 Jan;84(1):11-7. doi: 10.1002/jmv.22264. Epub 2011 Nov 3. J Med Virol. 2012. PMID: 22052690

9

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system.

Thoelen S, Van Damme P, Mathei C, Leroux-Roels G, Desombere I, Safary A, Vandepapeliere P, Slaoui M, Meheus A. Thoelen S, et al. Among authors: van damme p. Vaccine. 1998 Apr;16(7):708-14. doi: 10.1016/s0264-410x(97)00254-5. Vaccine. 1998. PMID: 9562690 Clinical Trial.

10

The first combined vaccine against hepatitis A and B: an overview.

Thoelen S, Van Damme P, Leentvaar-Kuypers A, Leroux-Roels G, Bruguera M, Frei PC, Bakasenas V, Safary A. Thoelen S, et al. Among authors: van damme p. Vaccine. 1999 Mar 26;17(13-14):1657-62. doi: 10.1016/s0264-410x(98)00421-6. Vaccine. 1999. PMID: 10194819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,229 results

Search Page